November 9th, 2018


DeCell Technologies Inc. and RegenMed—Ontario’s Premiere Tissue Bank—have signed partnership agreements to manufacture DermGEN™ for both domestic and international sales. RegenMed will both manufacture and distribute DermGEN™ in Canada while also manufacturing DermGEN™ for the International markets. In a separate deal, DeCell has partnered with Impactful Health Solutions (IHS) out of New Jersey, U.S.A., to begin sales of DermGEN™ in markets located in the Middle East. These agreements allow DermGEN™ to enter the healthcare market place so that clinicians can have an advanced, cost effective solution to treat chronic and acute wounds.


DECELL STRIKES KEY PARTNERSHIPS
.pdf
Download PDF • 94KB

November 20th, 2014

DeCell Technologies was selected as 1 of 3 finalists in the Innovation Category for the 2014 Discovery Awards and has been selected again as a finalist in the Innovation category for the 2015 Discovery Awards.


June 17th, 2014

DeCell Technologies Inc. was voted as the Best Presenting Company for Early Stage Growth at the 2014 Atlantic Venture Forum. A huge thank you to our sponsors, keynote speakers, panelists, presenting companies, investors, industry advisory board, and general delegates for making the 2nd annual Atlantic Venture Forum a tremendous success! We look forward to seeing you again at our 2015 Forum happening on June 16 & 17, 2015! The Atlantic Venture Forum was pleased to host 26 of the hottest early and growth stage companies on the Atlantic coast. We look forward to watching these companies excel and wish them all the best! Congratulations to the winners of the 2014 Atlantic Venture Forum.


DECELL VOTED BEST PRESENTING COMPANY
.pdf
Download PDF • 279KB